Disease Domain | Count |
---|---|
Nervous System Diseases | 1 |
Immune System Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 1 |
Top 5 Target | Count |
---|---|
COX(Cyclooxygenases) | 1 |
Target |
Mechanism COX inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date31 Jan 1991 |
Target |
Mechanism PBPs inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date31 Jan 1989 |
Target |
Mechanism COX inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1986 |
Start Date20 Nov 2012 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Etodolac ( COX ) | Osteoarthritis More | Approved |
Pentagastrin ( CCKB ) | Diagnostic agents More | Withdrawn |
Clofibrate ( PPARα ) | Hyperlipidemias More | Withdrawn |
Dicloxacillin Sodium ( PBPs ) | Staphylococcal Infections More | Withdrawn |
Cefpiramide Sodium ( PBPs ) | Bacterial Infections More | Withdrawn |